Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 6 publications
Enhancing brain entry and therapeutic activity of chimeric antigen receptor T cells with intra-arterial NEO100 in a mouse model of CNS lymphoma.
Journal: Journal of neurosurgery
Published: June 26, 2023
Enhanced brain entry of checkpoint-inhibitory therapeutic antibodies facilitated by intraarterial NEO100 in mouse models of brain-localized malignancies.
Journal: Journal of neurosurgery
Published: June 16, 2022
Spatio-temporal biodistribution of 89Zr-oxine labeled huLym-1-A-BB3z-CAR T-cells by PET imaging in a preclinical tumor model.
Journal: Scientific reports
Published: April 01, 2021
NEO100 enables brain delivery of blood‒brain barrier impermeable therapeutics.
Journal: Neuro-oncology
Published: September 03, 2020
A Humanized Lym-1 CAR with Novel DAP10/DAP12 Signaling Domains Demonstrates Reduced Tonic Signaling and Increased Antitumor Activity in B-Cell Lymphoma Models.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: October 18, 2019
Lym-1 Chimeric Antigen Receptor T Cells Exhibit Potent Anti-Tumor Effects against B-Cell Lymphoma.
Journal: International journal of molecular sciences
Published: November 28, 2017
Showing 1-6 of 6
Last Updated: 09/26/2026